UK Trial Gives Voice to CLL Patients» Experiences with Targeted Therapies

Traditionally, clinical trials report adverse events from a clinical perspective, but the patient’s experience with targeted therapies is often not fully considered, except in nonspecific patient-reported outcome studies. To address this gap, Dr. Dima El-Sharkawi
Consultant Haematologist, the Royal Marsden Hospital is conducting a trial in the UK, interviewing patients on targeted therapies for CLL.